|
SIKE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.32158736679366E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.83769732343376E-11 |
| Normal-vs-Stage2 |
1.842690E-03 |
| Normal-vs-Stage3 |
8.55981951985996E-14 |
| Normal-vs-Stage4 |
1.65756297576536E-12 |
| Stage1-vs-Stage2 |
7.724100E-02 |
| Stage1-vs-Stage3 |
1.810320E-02 |
| Stage1-vs-Stage4 |
2.156300E-03 |
| Stage2-vs-Stage3 |
5.741900E-03 |
| Stage2-vs-Stage4 |
5.376200E-04 |
| Stage3-vs-Stage4 |
2.167400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.32587340685131E-15 |
| Normal-vs-AfricanAmerican |
4.81139999997104E-06 |
| Normal-vs-Asian |
5.96740001856944E-09 |
| Caucasian-vs-AfricanAmerican |
6.938400E-01 |
| Caucasian-vs-Asian |
9.416600E-01 |
| AfricanAmerican-vs-Asian |
7.678600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.40369979265643E-10 |
| Normal-vs-Female |
2.87136980858804E-12 |
| Male-vs-Female |
7.298600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.5833999666981E-09 |
| Normal-vs-Age(41-60Yrs) |
2.09865458344893E-12 |
| Normal-vs-Age(61-80Yrs) |
1.56549995189437E-10 |
| Normal-vs-Age(81-100Yrs) |
2.798700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.218360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.954000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.259200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.038600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.892200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.650800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.567520E-02 |
| Classical-VS-Follicular |
9.643300E-04 |
| Classical-VS-Other |
5.687200E-01 |
| Classical-VS-Normal |
1.63846713974181E-12 |
| Tall-VS-Follicular |
3.43550000003745E-06 |
| Tall-VS-Other |
2.572400E-01 |
| Tall-VS-Normal |
9.60098667235343E-12 |
| Follicular-VS-Other |
5.435600E-01 |
| Follicular-VS-Normal |
9.164900E-04 |
| Other-VS-Normal |
2.038000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.00580005330175E-09 |
| Normal-vs-N1 |
4.14601686316018E-12 |
| N0-vs-N1 |
1.734260E-02 |
|
|
